Yi‐Zhou Jiang

机构：Shanghai Medical College of Fudan University, Fudan University, Fudan University Shanghai Cancer Center · ORCID：0000-0003-3699-2630

发表论文 440 篇 · 总被引 10406 次 · h-index 53

代表论文

• Migration of immune cells in tumors and inflammation: molecular mechanisms and therapeutic targets (2026 · Signal Transduction and Targeted Therapy)
• ZNF689 loss impairs homologous recombination sensitizing triple-negative breast cancer to combined PARP and PD-L1 inhibition (2026 · Nature Communications)
• Spatially interpretable artificial intelligence framework to tailored neoadjuvant dual HER2 blockade in HER2-positive breast cancer (2026 · Signal Transduction and Targeted Therapy)
• Figure S3 from IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer (2026)
• Figure S3 from IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer (2026)
• Figure S7 from IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer (2026)